0001125345-20-000162.txt : 20201230 0001125345-20-000162.hdr.sgml : 20201230 20201230160544 ACCESSION NUMBER: 0001125345-20-000162 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201229 FILED AS OF DATE: 20201230 DATE AS OF CHANGE: 20201230 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Risser Eric Blasius CENTRAL INDEX KEY: 0001587774 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36112 FILM NUMBER: 201425917 MAIL ADDRESS: STREET 1: 9640 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MACROGENICS INC CENTRAL INDEX KEY: 0001125345 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: Rockville STATE: MD ZIP: 20850 BUSINESS PHONE: 301-251-5172 MAIL ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 wf-form4_160936233075653.xml FORM 4 X0306 4 2020-12-29 0 0001125345 MACROGENICS INC MGNX 0001587774 Risser Eric Blasius 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 0 1 0 0 Sr VP & Chief Business Officer Common Stock 2020-12-29 4 M 0 500 1.51 A 44968 D Common Stock 2020-12-29 4 S 0 500 24.10 D 44468 D Employee stock option (right to buy) 1.51 2020-12-29 4 M 0 500 0 D 2013-07-06 2023-01-05 Common Stock 500.0 8500 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2019. This transaction was executed in multiple trades at prices ranging from $23.16 to $24.45. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Lynn Cilinski, Attorney-in-Fact 2020-12-30